Latest Regulatory Approvals News

Environmental Clean Technologies Limited has formed a joint venture and launched field trials for its innovative COLDry lignite-nitrogen fertiliser, marking a pivotal step toward commercialisation and revenue generation.

Heavy Minerals Limited advances steadily on its Port Gregory Garnet Project, with the Pre-Feasibility Study nearing completion and critical permitting and sales groundwork underway.

Burley Minerals Ltd reports significant progress in its Western Australian iron ore projects, highlighted by promising high-grade assay results and imminent drilling campaigns, while actively exploring strategic funding options amid recent sector M&A activity.

Cadoux Limited reports significant progress in its high purity alumina and Minhub rare earths projects, alongside robust environmental, social, and governance initiatives.

Recce Pharmaceuticals has gained key regulatory and ethics approvals for its Phase 3 clinical trial in Indonesia and completed patient dosing for its Phase II trial, while securing a substantial A$6.75 million R&D tax rebate to bolster its financial position.

Cardiex has kicked off deliveries of its CONNEQT Pulse arterial health monitors in the U.S., reporting strong preorder momentum and a 150% sales increase in December. The company’s strategic operational shifts and pharma partnerships set the stage for sustained growth in 2025.

St George Mining Limited progresses its strategic acquisition of the Araxá Niobium-REE Project while reporting promising exploration results across multiple Australian projects, underpinning its critical metals ambitions.

Bounty Oil and Gas NL reports steady cash reserves and rising oil production in Queensland, while facing regulatory setbacks offshore. The company’s strategic developments and entitlement offer position it for growth in 2025.

Poseidon Nickel Limited and Horizon Minerals Limited have secured decisive shareholder approval for their merger via schemes of arrangement, marking a pivotal step toward creating a new mid-cap mining entity in Western Australia.

Manuka Resources reports a maiden silver reserve at its Wonawinta Silver Mine and progresses its Taranaki VTM Iron Sands Project under new New Zealand legislation, bolstering its growth prospects and financial position.

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.

Classic Minerals Limited has agreed to sell its Kat Gap gold tenements to Bain Global Resources for A$7 million, aiming to reduce debt and refocus on other exploration projects. The deal awaits shareholder approval and regulatory clearances.